PhRMA Willing To Contribute To Drug ‘Affordability’ – But Mum On How Much

 
• By Cathy Kelly

PhRMA CEO Steven Ubl offers list of policy alternatives to drug pricing bills pending in the US Congress that he argues would stifle innovation; industry's plans, on the other hand, could produce "meaningful" legislation.

Washington DC Capitol dome detail with waving american flag
PhRMA Expects Drug Pricing Legislation This Year

More from Pricing Debate

More from Market Access